Rapid cognitive decline in Alzheimer's disease: a literature review

References

• Abellan van Kan, G., Rolland, Y., Nourashemi, F., Coley, N., Andrieu, S. & Vellas, B., on behalf of the REAL.FR group. (2009). Cardiovascular risk factors and progression of Alzheimer's disease. Alzheimer Disease and Associated Disorders, 27, 240–246.
   Google Scholar
• Adak S., Illouz, M., Gorman M., Tandon, R., Zimmerman, E., Guariglia, B., … Kaye, J. (2004). Predicting the rate of cognitive decline in aging and early Alzheimer disease. Neurology, 63, 108–111.
   PubMed Web of Science ®Google Scholar
• AD International. (2009). World Alzheimer Report. London: Alzheimer's Disease International.
   Google Scholar
• Aguero-Torres, H., Fratiglioni, L., Zhenchao, G., Viitanen, M. & Winblad, B. (1998). Prognostic factors in very old demented adults: A seven year follow up from a population-based survey in Stockholm. Journal of the American Geriatrics Society, 46, 444–452.
   PubMed Web of Science ®Google Scholar
• Alexander, G.E., Furey, M.L., Grady, C.L., Pietrini, P., Mentis, M.J. & Schapiro, M.B. (1997). Association of premorbid function with cerebral metabolism in Alzheimer's disease: Implications for the reserve hypothesis. American Journal of Psychiatry, 154, 165–172.
   PubMed Web of Science ®Google Scholar
• Allan, C.L. & Ebmeier, K.P. (2010). The influence of ApoE4 on clinical progression of dementia: A meta-analysis. International Journal of Geriatric Psychiatry, 25, 1–7.
   PubMed Web of Science ®Google Scholar
• Amieva, H., Jaqmin-Gadda, H., Orgogozo, J., Le Carret M., Helmer, C., Letteneur, L., … Dartigues, J. (2005). The 9 year cognitive decline before dementia of the Alzheimer type: A prospective population-based study. Brain, 128, 1093–1101.
   PubMed Web of Science ®Google Scholar
• Anstey, K.J., von Sanden, C., Salim, A. & O’Kearney, R. (2007). Smoking as a risk factor for dementia and cognitive decline: A meta-analysis of prospective studies. American Journal of Epidemiology, 166, 367–378.
   PubMed Web of Science ®Google Scholar
• Backman, L., Jones, S., Small, B.J., Aguero-Torres, H. & Fratiglioni, L. (2003). Rate of cognitive decline in preclinical Alzheimer's disease: The role of comorbidity. Journal of Gerontology Psychological Sciences, 58B, 228–236.
   Google Scholar
• Basun, H., Grut, M., Winblad, B. & Lannfelt, L. (1995). Apolipoprotein epsilon 4 allele and disease progression in patients with late-onset Alzheimer's disease. Neuroscience Letters, 183, 32–34.
   PubMed Web of Science ®Google Scholar
• Bellew, K.M., Pigeon, J.G., Stang, P.E., Fleischman, W., Gardner, R.M. & Baker, W.W. (2004). Hypertension and the rate of cognitive decline in patients with dementia of the Alzheimer type. Alzheimer Disease and Associated Disorders, 18, 208–213.
   PubMed Web of Science ®Google Scholar
• Berr, C., Wancata, J. & Ritchie, K. (2005). Prevalence of dementia in the elderly in Europe. European Neuropsychopharmacology, 15, 463–471.
   PubMed Web of Science ®Google Scholar
• Bhargava, D., Weiner, M.F., Hynan, L.S., Diaz-Arrastia, R. & Lipton, A.M. (2006). Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology, 19, 78–82.
   PubMed Web of Science ®Google Scholar
• Bowler, J.V., Munoz, D.G., Merskey, H. & Hachinski, V. (1998). Factors affecting the age of onset and rate of progression of Alzheimer's disease. Journal of Neurology Neurosurgery and Psychiatry, 65, 184–190.
   PubMed Web of Science ®Google Scholar
• Burns, A., Jacoby, R. & Levy, R. (1991). Progression of cognitive impairment in Alzheimer's disease. Journal of the American Geriatrics Society, 39, 39–45.
   PubMed Web of Science ®Google Scholar
• Capitani, E., Cazzaniga, R., Francescani, A. & Spinnler, H. (2004). Cognitive deterioration in Alzheimer's disease: Is the early course predictive of the later stages? Neurological Sciences, 25, 198–204.
   PubMed Web of Science ®Google Scholar
• Carcaillon, L., Peres, K, Pere, J.J., Helmer, C., Orgogozo, J.M. & Dartigues, J.F. (2007). Fast cognitive decline at the time of dementia diagnosis: A major prognostic factor for survival in the community. Dementiua and Geriatric Cognitive Disorders, 24, 138–145.
   PubMed Web of Science ®Google Scholar
• Cortes, F., Gillette-Guyonnet, S., Nourashemi, F., Christelle, C. & Vellas, B. (2006). Family history of dementia does not influence the progression of Alzheimer's disease at two years: Results from the REAL.FR study. American Journal of Alzheimer Disease and Other Dementias, 21, 131–136.
   PubMedGoogle Scholar
• Cosentino S., Scarmeas, N., Helzner, E. Glymour, M., Brandt, J., Albert, M., … Stern, Y. (2008). APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology, 70, 1842–1849.
   PubMed Web of Science ®Google Scholar
• Craft, S., Teri, L., Edland, S., Kukull, W., Schellenberg, G., McCormick, W., … Larsen, E. (1998). Accelerated decline in apolipoprotein E-epsilon 4 homozygotes with Alzheimer's disease. Neurology, 51, 149–153.
   PubMed Web of Science ®Google Scholar
• Dal Forno, G., Rassmusson, G., Brandt, J., Carson, K., Brookmeyer, R., Troconso, K. & Kawas, C. (1996). Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Archives of Neurology, 53, 345–350.
   PubMed Web of Science ®Google Scholar
• Deschaintre, Y., Richard, F., Leys, D. & Pasquier, F. (2009). Treatment of vascular risk factors is associated with slower decline in Alzheimer disease. Neurology, 73, 674–680.
   PubMed Web of Science ®Google Scholar
• Doody, R.S., Massman, P. & Dunn, K. (2001). A method for estimating progression rates in Alzheimer's disease. Archives of Neurology, 58, 449–454.
   PubMedGoogle Scholar
• Doody, R.S., Pavlik, V., Massman, P., Rountree, S., Darby, E. & Chan, W. (2010). Predicting progression of Alzheimer's disease. Alzheimer's Research and Therapy, 2, 2–9.
   PubMed Web of Science ®Google Scholar
• Evans, R.M., Hui, S., Perkins, A., Lahiri, D.K., Poirier, J. & Farlow, M.R. (2004). Cholesterol and APOE genotype interact to influence Alzheimer disease progression. Neurology, 62, 1869–1871.
   PubMed Web of Science ®Google Scholar
• Flicker, L. (2010). Screening and assessment instruments for the detection and measurement of cognitive impairment. In D. Ames, A. Burns, and J. O’Brien, (Eds), Dementia (4th ed.) (p. 57). London: Hodder Arnold.
   Google Scholar
• Frisoni, G.B., Govoni, S., Goroldi, C., Bianchetti, A., Calabresi, L., Francheschini, G. & Trabucchi, M. (1995). Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Annals of Neurology, 37, 596–604.
   PubMed Web of Science ®Google Scholar
• Frisoni, G.B., Henneman, W., Weiner, M., Scheltens, P., Vellas, B., Reynish, E. … the Alzheimer's Disease Neuroimaging Initiative. (2008). The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium. Alzheimer's Dementia, 4, 255–264.
   PubMed Web of Science ®Google Scholar
• Fritsch, T., McClendon, M.J., Smyth, K.A. & Ogrocki, P.K. (2002). Effects of educational attainment and occupational status on cognitive and functional decline in persons with Alzheimer-type dementia. International Psychogeriatrics, 14, 347–363.
   PubMed Web of Science ®Google Scholar
• Gomez-Isla, T., West, W., Rebeck, G., Harr, S., Growdon, J., Locasio, J., … Hyman, B. (1996). Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Annals of Neurology, 39, 62–70.
   PubMed Web of Science ®Google Scholar
• Growdon, J.H., Locascio, J.J., Corkin, S., Gomez-Isla, T. & Hyman, B.T. (1996). Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology, 47, 444–448.
   PubMed Web of Science ®Google Scholar
• Helzner, E.P., Luchsinger, J., Scarmeas, N., Cosentino, S., Brickman, A., Glymour, M. & Stern, Y. (2009). Contribution of vascular risk factors to the progression in alzheimer disease. Archives of Neurology, 66, 343–348.
   PubMedGoogle Scholar
• Hirono, N., Hashimoto, M., Yasuda, M., Kazui, H. & Mori, E. (2003). Accelerated memory decline in Alzheimer's disease with apolipoprotein ϵ4 allele. Journal of Neuropsychiatry and Clinical Neuroscience, 15, 354–358.
   PubMed Web of Science ®Google Scholar
• Ho, G.J., Hansen, L., Alford, M., Foster, K., Salmon, D., Galasko, D., … Masliah, E. (2002). Age at onset is associated with disease severity in Lewy body variant and Alzheimer's disease. Neuroreport, 13, 1825–1828.
   PubMed Web of Science ®Google Scholar
• Holmes, C., Levy, R., McLoughlin, D.M., Powell, J.F. & Lovestone, S. (1996). Apolipoprotein E: Non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease. Journal of Neurology Neurosurgery and Psychiatry, 61, 580–583.
   PubMed Web of Science ®Google Scholar
• Holthouse, C. & Gubbay, S.S. (1997). Alzheimer's disease: Clinical predictors of rates of intellectual decline – A prospective study. Age and Ageing, 26, 407–410.
   PubMed Web of Science ®Google Scholar
• Holtzer, R., Wegesin, D., Albert, S., Marder, K., Bell, K., Albert, M., … Stern, Y. (2003). The rate of cognitive decline and risk of reaching clinical milestones in Alzheimer's disease. Archives of Neurology, 60, 1137–1142.
   PubMedGoogle Scholar
• Hoyt, B.D., Massman, P.J., Schatschneider, C., Cooke, N. & Doody, R.S. (2005). Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease. Archives of Neurology, 62, 454–459.
   PubMedGoogle Scholar
• Ito, K., Corrigan, B., Zhao, Q., French, J., Miller, R., Soares, H., … Fullerton, T. (2010). Disease progression model for cognitive deterioration from Alzheimer's Disease Neuroimaging Initiative database. Alzheimer's and Dementia, 1, 10.
   Google Scholar
• Jacobs, D., Sano, M., Marder, K., Bell, K., Bylsma, F., Lafleche, G., … Stern, Y. (1990). Age at onset on Alzheimer's disease: Relation to pattern of cognitive dysfunction and rate of decline. Neurology, 40, 8–14.
   PubMed Web of Science ®Google Scholar
• Jonker, C., Schmand, B., Lindeboom, J., Havekes, L.M. & Launer, L.J. (1998). Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Archives of Neurology, 55, 1065–1069.
   PubMedGoogle Scholar
• Katzman, R., Brown, T., Thal, L., Fuld, P., Aronson, M., Butters, N., … Terry, R. (1988). Comparison of annual rate of change of mental status score in four independent studies of patients with Alzheimer's disease. Annals of Neurology, 24, 384–389.
   PubMed Web of Science ®Google Scholar
• Kim, J.M., Shin, I.S. & Yoon, J.S. (2002). Apolipoprotein E among Korean Alzheimer's disease patients in community-dwelling and hospitalized elderly samples. Dementia and Geriatric Cognitive Disorders, 13, 119–124.
   PubMed Web of Science ®Google Scholar
• Kleiman, T., Zdanys, K., Black, B., Rightmer, T., Grey, M., Garman, K…van Dyck, C. (2006). Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: Retrospective and prospective analysis. Dementia and Geriatric Cognitive Disorders, 22, 73–82.
   PubMed Web of Science ®Google Scholar
• Kramer-Ginsberg, E., Mohs, R., Aryan, M., Lobel, D., Silverman, J., Davidson, M. & Davis, K. (1988). Clinical predictors of course for Alzheimer patients in a longitudinal study: A preliminary report. Psychopharmacology Bulletin, 24, 458–462.
   PubMedGoogle Scholar
• Kurz, A., Egensperger, R., Haupt, M., Lautenschlager, N., Romero, B., Graebner, M. & Muller, U. (1996). Apolipoprotein E epsilon 4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease. Neurology, 47, 440–443.
   PubMed Web of Science ®Google Scholar
• Laske, C., Stellos, K., Hoffmann, N., Stransky, E., Straten, G., Eschweiler, G. & Leyhe, T. (2010). Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients. International Journal of Neuropsychopharmacolology, 22, 1–6.
   Google Scholar
• Lee, J.H., Olichney, J., Hansen, L.A., Hofstetter, C.R. & Thal, L. (2007). Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Archives of Neurology, 57, 1474–1479.
   Google Scholar
• Locascio, J.J., Fukumoto, H., Yap, L., Bottiglieri, T., Growdon, J., Hyman, B. & Irizarry, M. (2008). Plasma amyloid β-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease. Archives of Neurology, 65, 776–785.
   PubMed Web of Science ®Google Scholar
• Lucca, U., Comelli, M., Tettamanti, M., Tiraboschi, P. & Spagnoli, A. (1993). Rate of progression and prognostic factors in Alzheimer's disease: A prospective study. Journal of the American Geriatrics Society, 41, 45–49.
   PubMed Web of Science ®Google Scholar
• Mann, U.M., Mohr, E. & Chase, T.N. (1989). Rapidly progressing Alzheimer's disease. Lancet, 2(8666), 799.
   PubMed Web of Science ®Google Scholar
• Martins, C.A.L., Oulhaj, A., de Jager, C.A. & Williams, J.H. (2005). APOE alleles predict the rate of cognitive decline in Alzheimer disease. A non-linear model. Neurology, 65, 1888–1893.
   PubMed Web of Science ®Google Scholar
• Masse, I., Bordet, R., Deplanque, D., Al Khedr, A., Richard, F., Libersa, C. & Pasquier, F. (2005). Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease. Journal of Neurology Neurosurgery and Psychiatry, 76, 1624–1629.
   PubMed Web of Science ®Google Scholar
• McGuinness, B., O’Hare, J., Craig, D., Bullock, R., Malouf, R. & Passmore, P. (2010). Statins for the treatment of dementia. Cochrane Database of Systems Review, 8, CD007514.
   PubMed Web of Science ®Google Scholar
• Mendiondo, M.S., Ashford, J.W., Kryscio, R.J. & Schmitt, F.A. (2000)Modeling Mini Mental State Examination changes in Alzheimer's disease. Statistical Medicine, 19, 1607–1616.
   PubMed Web of Science ®Google Scholar
• Mielke, M.M., Rosenberg, P., Tschanz, J., Cook, L., Corcoran C., Hayden, K., … Lyketsos, C. (2007). Vascular factors predict rate of progression in Alzheimer disease. Neurology, 69, 1850–1858.
   PubMed Web of Science ®Google Scholar
• Morris, J.C., Edland, S., Clark, C., Galasko, Koss, E., Mohs, R., … Heyman, A. (1993). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology, 43, 2457–2465.
   PubMed Web of Science ®Google Scholar
• Mungas, D., Reed, B.R., Ellis, W.G. & Jagust, W. (2001). The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease. Archives of Neurology, 58, 1243–1247.
   PubMed Web of Science ®Google Scholar
• Murphy, G.M., Taylor, J., Kraemer, H.C., Yesavage, J. & Tinklenberg, J.R. (1997). No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease. American Journal of Psychiatry, 154, 603–608.
   PubMed Web of Science ®Google Scholar
• Musicco, M., Palmer, K., Salamone, G., Luppo, F., Perry, R., Mosti, S., … Caltagirone, C. (2009). Predictors of progression of cognitive decline in Alzheimer's disease: The role of vascular and sociodemographic factors. Journal of Neurology, 256, 1288–1295.
   PubMed Web of Science ®Google Scholar
• Musicco, M., Salamone, G., Caltagirone, C., Cravello, L., Fadda, L., Lupo, F, … Palmer, K. (2010). Neuropsychological predictors of rapidly progressing patients with Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 30, 219–228.
   PubMed Web of Science ®Google Scholar
• Neumann, P.J., Araki S., Arcelus, A., Longo, A., Papadopoulos, G., Kosic, K., … Bhattacharya, A. (2001). Measuring Alzheimer's disease progression with transition probabilities. Estimates from CERAD. Neurology, 57, 957–964.
   PubMed Web of Science ®Google Scholar
• O’Hara, R., Thompson, J., Kraemer, H., Fenn, C., Taylor, J., Ross, L., … Tinklenberg, J. (2002). Which Alzheimer patients are at risk for rapid cognitive decline? Journal of Geriatric Psychiatry and Neurology, 15, 233–238.
   PubMed Web of Science ®Google Scholar
• Ortof, E. & Crystal, H.A. (1989). Rate of progression of Alzheimer's disease. Journal of the American Geriatrics Society, 37, 511–514.
   PubMed Web of Science ®Google Scholar
• Ousset, P.J., Nourhashemi, F., Reynish, E. & Vellas, B. (2008). Nutritional status is associated with disease progression in very mild Alzheimer disease. Alzheimer Disease and Associated Disorders, 22, 66–71.
   PubMed Web of Science ®Google Scholar
• Peters, R., Poulter, R., Warner, J., Beckett, N., Burch, L. & Bulpitt, C. (2008). Smoking, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatrics, 8, 36.
   PubMedGoogle Scholar
• Plastino, M., Fava, A., Pirritano, D., Cotronei, P., Sacco, N., Sperli, T., … Bosco, D. (2009). Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2. Journal of the Neurological Sciences, 288, 112–116.
   Web of Science ®Google Scholar
• Rasmusson, D.X., Carson, K.A., Brookmeyer, R., Kawas, C. & Brandt, J. (1996). Predicting rate of cognitive decline in probable Alzheimer's disease. Brain Cognition, 31, 133–147.
   PubMed Web of Science ®Google Scholar
• Regan, C., Katona, C., Walker, Z., Hooper, J., Donovan, J. & Livingstone, G. (2006). Relationship of vascular risk to the progression of Alzheimer disease. Neurology, 67, 1357–1362.
   PubMed Web of Science ®Google Scholar
• Roselli, F., Tartaglione, B., Federico, F., Lepore, V., Defazio, G. & Livrea, P. (2009). Rate of MMSE score change in Alzheimer's disease: Influence of education and vascular risk factors. Clinical Neurology and Neurosurgery, 111, 327–330.
   PubMed Web of Science ®Google Scholar
• Rosenstein, L.D. (1998). Differential diagnosis of the major progressive dementias and depression in middle and late adulthood: A summary of the literature of the early 1990s. Neuropshycological Reviews, 8, 109–167.
   PubMed Web of Science ®Google Scholar
• Sanz, C., Andrieu, S., Sinclair, A., Hanaire, H. & Vellas, B., for the REAL.FR Study Group. (2009). Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease. Neurology, 73, 1359–1366.
   PubMed Web of Science ®Google Scholar
• Savva, G.M., Wharton, S.B., Ince, P.G., Forster, G., Matthews, F.E. & Brayne, C. (2009). Age, neuropathology and dementia. New England Journal of Medicine, 360, 2302–2309.
   PubMed Web of Science ®Google Scholar
• Scarmeas, N., Albert, S.M., Manly, J.J. & Stern, Y. (2006). Education and rate of cognitive decline in incident Alzheimer's disease. Journal of Neurology Neurosurgery Psychiatry, 77, 308–316.
   PubMed Web of Science ®Google Scholar
• Sheng, B., Cheng, L.F., Law, C.B., Li, H.L., Yeung, K.M. & Lau, K.K. (2007). Coexisting cerebral infarction in Alzheimer's disease is associated with fast dementia progression: Applying the National Institute for Neurological Disorders and Stroke/Association Internationale pour la Recherche et l’Enseignement en Neurosciences Neuroimaging criteria in Alzheimer's disease with concomitant cerebral infarction. Journal of the American Geriatrics Society, 55, 918–922.
   PubMed Web of Science ®Google Scholar
• Sluimer, J.D., Vrenken, H., Blankenstein, M., Fox, N., Scheltens, P., Barkhof, F. & van der Flier, W.M. (2008). Whole-brain atrophy rate in Alzheimer disease: Identifying fast progressors. Neurology, 70, 1836–1841.
   PubMed Web of Science ®Google Scholar
• Soto, M.E., Andrieu, S., Arbus, C., Ceccaldi, M., Couratier, P., Dantoine, T., … Vellas, B. (2008a). Rapid cognitive decline in Alzheimer disease. Consensus paper. Journal of Nutrition Health and Aging, 12, 703–713.
   PubMed Web of Science ®Google Scholar
• Soto, M.E., Andrieu, S., Cantet, C., Reynish, E., Ousset, P., Arbus, C., … REAL.FR group. (2008b). Predictive value of rapid decline in Mini Mental State Examination in clinical practice for prognosis in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 26, 109–116.
   PubMed Web of Science ®Google Scholar
• Soto, M.E., Gillette-Guyonnet, S., Vellas, B. & the REAL.FR group. (2005). Rapid cognitive decline: Searching for a definition and predictive factor among elderly with Alzheimer's disease. Journal of Nutrition, Health and Aging, 9, 158–161.
   PubMed Web of Science ®Google Scholar
• Sparks, D.L., Sabbah, N., Connor, D., Lopez, J., Lowner, L., Browne, P., … Ziolwoski, C. (2005). Atorvastatin for the treatment of mild to moderate Alzheimer disease. Preliminary results. Archives of Neurology, 62, 753–757.
   PubMed Web of Science ®Google Scholar
• Stern, R.G., Albert, M. & Mayeux, R. (1994). A longitudinal study of Alzheimer's disease: Measurement, rate and predictors of cognitive deterioration. American Journal of Psychiatry, 151, 390–396.
   PubMed Web of Science ®Google Scholar
• Stern, Y., Alexander, G.E., Prohovnik, I. & Mayew, R. (1992). Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease. Annals of Neurology, 32, 371–375.
   PubMed Web of Science ®Google Scholar
• Stern, Y., Albert, S., Tang, M.X. & Tsai, W.Y. (1999). Rate of memory decline in AD is related to education and occupation: Cognitive reserve? Neurology, 53, 1942–1947.
   PubMed Web of Science ®Google Scholar
• Stern, Y., Brandt J. Albert, M. Jacobs, D., Liu, X., Bell, K., … Mayeux, R. (1997). The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease. Annals of Neurology, 41, 615–620.
   PubMed Web of Science ®Google Scholar
• Storandt, M., Grant, E.A., Miller, J.P. & Morris. J.C. (2002). Rates of progression in mild cognitive impairment and early Alzheimer disease. Neurology, 59, 1034–1041.
   PubMed Web of Science ®Google Scholar
• Suh, G.H., Ju, Y.S., Yeon, B.K. & Shah, A. (2004). A longitudinal study of Alzheimer's disease: Rates of cognitive and functional decline. International Journal of Geriatric Psychiatry, 19, 817–824.
   PubMed Web of Science ®Google Scholar
• Swanwick, G.R.J., Coen, R.F., Coakley, D. & Lawlor, B.A. (1998). Assessment of progression and prognosis in ‘possible’ and ‘probable’ Alzheimer's disease. International Journal of Geriatric Psychiatry, 13, 331–335.
   PubMed Web of Science ®Google Scholar
• Teri, L., McCurry, S.M., Edland, S.D., Kukull, W.A. & Larson, E.B. (1995). Cognitive decline in Alzheimer's disease: A longitudinal investigation of risk factors for accelerated decline. Journal of Gerontology Series A: Biological Sciences and Medical Sciences, 50, M49–M55.
   Web of Science ®Google Scholar
• Wilson, R.S., Li, Y., Aggarwal, N., Barnes L., McCann, A., Gilley D. & Evans D. (2004). Education and the course of cognitive decline in Alzheimer disease. Neurology, 63, 1198–1202.
   PubMed Web of Science ®Google Scholar
• Wilson, R.S., McCann, J.J., Li, Y., Aggarwal, N.T., Gilley, D.V. & Evans, D.A. (2007). Nursing home placement, day care use, and cognitive decline in Alzheimer's disease. American Journal of Psychiatry, 164, 910–916.
   PubMed Web of Science ®Google Scholar